FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+18.86%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$16.1B
AUM Growth
+$16.1B
(+14%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
31.86%
Holding
165
New
37
Increased
28
Reduced
33
Closed
28
Top Buys
| 1 |
Aramark
ARMK
|
$424M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$362M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$351M |
| 4 |
RTX Corp
RTX
|
$325M |
| 5 |
Broadcom
AVGO
|
$273M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$498M |
| 2 |
AbbVie
ABBV
|
$332M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$299M |
| 4 |
Palo Alto Networks
PANW
|
$217M |
| 5 |
Bristol-Myers Squibb
BMY
|
$217M |
Sector Composition
| 1 | Healthcare | 39.5% |
| 2 | Communication Services | 13.65% |
| 3 | Financials | 10.37% |
| 4 | Technology | 10.17% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Broadcom
AVGO
$1.42T
| $273M | 1.64% |
+622,995
| New | +$273M |
|
27
Blackstone
BX
$131B
| $252M | 1.52% |
3,891,886
+62,550
| +2% | +$4.05M |
|
28
Exelixis
EXEL
$9.95B
| $221M | 1.33% |
11,000,000
+250,000
| +2% | +$5.02M |
|
29
New Oriental
EDU
$7.98B
| $214M | 1.29% |
1,154,300
-214,478
| -16% | -$39.9M |
|
|
WORK
30
DELISTED
Slack Technologies, Inc.
WORK
| $207M | 1.25% |
+4,912,300
| New | +$207M |
|
31
Willis Towers Watson
WTW
$31.9B
| $203M | 1.22% |
962,500
+912,500
| +1,825% | +$192M |
|
|
IPHI
32
DELISTED
INPHI CORPORATION
IPHI
| $199M | 1.2% |
+1,239,800
| New | +$199M |
|
33
Alibaba
BABA
$325B
| $199M | 1.19% |
853,300
+240,715
| +39% | +$56M |
|
|
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $192M | 1.16% |
875,000
| – | – |
|
35
Hilton Worldwide
HLT
$64.7B
| $183M | 1.1% |
1,640,437
+94,560
| +6% | +$10.5M |
|
36
Qiagen
QGEN
$10.1B
| $172M | 1.04% |
+3,256,771
| New | +$172M |
|
37
TransUnion
TRU
$16.8B
| $172M | 1.03% |
1,734,082
-80,050
| -4% | -$7.94M |
|
38
Ascendis Pharma
ASND
$12.1B
| $167M | 1% |
1,000,000
-250,000
| -20% | -$41.7M |
|
39
Howmet Aerospace
HWM
$70.3B
| $140M | 0.84% |
4,891,479
-2,318,909
| -32% | -$66.2M |
|
|
MXIM
40
DELISTED
Maxim Integrated Products
MXIM
| $137M | 0.82% |
1,542,400
+312,400
| +25% | +$27.7M |
|
41
Apellis Pharmaceuticals
APLS
$3.51B
| $130M | 0.78% |
2,275,000
| – | – |
|
|
42
AbbVie
ABBV
$374B
| $123M | 0.74% |
1,150,000
-3,100,000
| -73% | -$332M |
|
|
AMRS
43
DELISTED
Amyris Inc.
AMRS
| $108M | 0.65% |
17,500,000
+3,500,000
| +25% | +$21.6M |
|
44
Sarepta Therapeutics
SRPT
$1.98B
| $102M | 0.62% |
600,000
| – | – |
|
45
PG&E
PCG
$33.7B
| $90.9M | 0.55% |
7,292,042
| – | – |
|
|
SAGE
46
DELISTED
Sage Therapeutics
SAGE
| $90.8M | 0.55% |
1,050,000
| – | – |
|
|
PLYA
47
DELISTED
Playa Hotels & Resorts
PLYA
| $89.2M | 0.54% |
14,994,867
-15,612,063
| -51% | -$92.9M |
|
48
Lufax Holding
LU
$2.66B
| $76.1M | 0.46% |
+5,357,750
| New | +$76.1M |
|
49
Enanta Pharmaceuticals
ENTA
$189M
| $74.7M | 0.45% |
1,775,000
| – | – |
|
|
BRMK
50
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $73.1M | 0.44% |
7,170,213
| – | – |
|